Tradestie Institutional Equity Comparison Engine

ENTA vs DMAC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DMAC Overall Edge

DMAC Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to DiaMedica Therapeutics Inc. Common Stock (DMAC) driven by superior Growth & Margin, Momentum & Technical while ENTA counters with relative strength in Valuation, Options & Structure. Fundamentally, ENTA trades at 44.0x Forward P/E with -90.0% operating margin (-21.6% YoY revenue) versus DMAC at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ENTA sits in BREAKDOWN (11th %ile IV; Dealer Gamma Walls on Pro) against DMAC sits in SURGE (14th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ENTA
ENTA 44.0x vs DMAC N/M Fwd P/E
Growth & Margin Winner DMAC
Op Margin -90.0% vs 0.0% ยท YoY -21.6% vs +0.0%
Momentum & Technical Winner DMAC
1Y -7.9% vs +54.8% ยท 52W Pos 10% vs 55%
Options & Structure Winner ENTA
BREAKDOWN (11th %ile IV) vs SURGE (14th %ile IV)
ENTA NASDAQ
Enanta Pharmaceuticals, Inc
Pharmaceutical Preparations
$10.79
-1.82% 1D
Market Cap $326.2M
1M Return -2.79%
1Y Return -7.94%
Forward P/E 44.0x
Unified AI Score
46.2 / 100 HOLD
Tech 53.0 Fund 54.0 Flow 67.0 Mom 50.0
DMAC NASDAQ
DiaMedica Therapeutics Inc. Common Stock
Pharmaceutical Preparations
$8.39
-4.55% 1D
Market Cap $503.1M
1M Return +10.83%
1Y Return +54.8%
Forward P/E N/M
Unified AI Score
46.3 / 100 HOLD
Tech 30.0 Fund 51.0 Flow 65.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ENTA -7.94% DMAC +54.8% Spread: +62.74 pp (DMAC Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ENTA Revenue DMAC Revenue ENTA Op. Margin DMAC Op. Margin Margin Edge
FY2018 $210M $0M 42.7% -1352.2% ENTA
FY2019 $210M N/A 17.9% N/A ENTA
FY2020 $120M N/A -34.0% N/A ENTA
FY2021 $100M N/A -112.9% N/A ENTA
FY2022 $90M N/A -143.7% N/A ENTA
FY2023 $80M N/A -173.2% N/A ENTA
FY2024 $70M N/A -179.9% N/A ENTA
FY2025 $70M N/A -130.7% N/A ENTA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ENTA (4) vs DMAC (5)
Institutional Metric ENTA DMAC Criterion Row Winner
Market Capitalization Scale $326.2M $503.1M Larger Scale DMAC
Trailing P/E Ratio Valuation 44.0x N/M Lower Multiple ENTA
Forward P/E Ratio Valuation 44.0x N/M Lower Multiple ENTA
Revenue Growth (YoY) Growth -21.6% +0.0% Higher Growth DMAC
Operating Margin (TTM) Profitability -90.0% 0.0% Higher Margin DMAC
Net Profit Margin Profitability -96.9% 0.0% Higher Margin DMAC
Return on Equity (ROE) Capital Efficiency -70.1% -114.6% Higher ROE ENTA
52-Week Range Position Momentum 10% ($10โ€“$17) 55% ($5โ€“$11) Stronger Trend DMAC
Beta / 30D Volatility Risk Regime 0.89ฮฒ ยท 58% Vol 1.72ฮฒ ยท 97% Vol Lower Realized Risk ENTA
Unified Institutional Score Composite Signal 46.2 / 100 (HOLD) 46.3 / 100 (HOLD) Higher Composite Tie

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ENTA vs DMAC Buy Guide
ENTA BREAKDOWN
95d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 11th %ile
IV Regime Compressed (<25th %ile)
Live ENTA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DMAC SURGE
8d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 14th %ile
IV Regime Compressed (<25th %ile)
Live DMAC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ENTA nor DMAC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.